Individualising cancer treatment for children with cancer REF UW00664

Are you a parent or carer of a child with acute lymphoblastic leukaemia (ALL) or osteogenic sarcoma (OGS)? Would you like to help researchers find a way to individualise treatment for these conditions and reduce the side effects of the treatment?

Applications close: Friday 29th September 2017

About the project

Researchers at The University of Western Australia are conducting a study to individualise the dosage of methotrexate, a drug commonly used to treat acute lymphoblastic leukaemia and osteogenic sarcoma, which can cause severe side effects.

About the position

Researchers would like a parent or carer of a child with acute lymphoblastic leukaemia or osteogenic sarcoma to join them as a research buddy.

The research buddy will use their lived experience to provide input and advice in developing the project.

What skills or experience do I need?

The research buddy will:

  • Be a parent or carer of a child with acute lymphoblastic leukaemia or osteogenic sarcoma
  • Have an interest in research looking at individualising cancer medicine

What is the time commitment?

Two years; you will meet with the researcher 1-2 times per year.

Where will meetings be held?

Meetings will be held at The University of Western Australia, Nedlands.

What support is offered?

A $30 honorarium per hour for meetings attended is offered. Free training and mentoring is also offered by the Consumer and Community Health Research Network.

Applications close: Friday 29th September 2017